117 related articles for article (PubMed ID: 14584518)
1. Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures.
Albin M; Björk J; Welinder H; Tinnerberg H; Mauritzson N; Billström R; Strömberg U; Mikoczy Z; Johansson B; Ahlgren T; Nilsson PG; Mitelman F; Hagmar L
Scand J Work Environ Health; 2003 Oct; 29(5):378-87. PubMed ID: 14584518
[TBL] [Abstract][Full Text] [Related]
2. Are occupational, hobby, or lifestyle exposures associated with Philadelphia chromosome positive chronic myeloid leukaemia?
Björk J; Albin M; Welinder H; Tinnerberg H; Mauritzson N; Kauppinen T; Strömberg U; Johansson B; Billström R; Mikoczy Z; Ahlgren T; Nilsson PG; Mitelman F; Hagmar L
Occup Environ Med; 2001 Nov; 58(11):722-7. PubMed ID: 11600728
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure.
West RR; Stafford DA; White AD; Bowen DT; Padua RA
Blood; 2000 Mar; 95(6):2093-7. PubMed ID: 10706879
[TBL] [Abstract][Full Text] [Related]
4. Myeloid leukemias and myelodysplastic syndromes: chemical exposure, histologic subtype and cytogenetics in a case-control study.
Ciccone G; Mirabelli D; Levis A; Gavarotti P; Rege-Cambrin G; Davico L; Vineis P
Cancer Genet Cytogenet; 1993 Jul; 68(2):135-9. PubMed ID: 8353805
[TBL] [Abstract][Full Text] [Related]
5. Smoking and myelodysplastic syndromes.
Björk J; Albin M; Mauritzson N; Strömberg U; Johansson B; Hagmar L
Epidemiology; 2000 May; 11(3):285-91. PubMed ID: 10784245
[TBL] [Abstract][Full Text] [Related]
6. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France.
Nisse C; Haguenoer JM; Grandbastien B; Preudhomme C; Fontaine B; Brillet JM; Lejeune R; Fenaux P
Br J Haematol; 2001 Mar; 112(4):927-35. PubMed ID: 11298587
[TBL] [Abstract][Full Text] [Related]
7. Integrating WHO 2001-2008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): a case-case analysis of benzene exposure.
Irons RD; Gross SA; Le A; Wang XQ; Chen Y; Ryder J; Schnatter AR
Chem Biol Interact; 2010 Mar; 184(1-2):30-8. PubMed ID: 19941839
[TBL] [Abstract][Full Text] [Related]
8. Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece.
Avgerinou C; Giannezi I; Theodoropoulou S; Lazaris V; Kolliopoulou G; Zikos P; Alamanos Y; Leotsinidis M; Symeonidis A
Hematology; 2017 Aug; 22(7):419-429. PubMed ID: 28102107
[TBL] [Abstract][Full Text] [Related]
9. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic findings in primary and secondary MDS.
Heim S
Leuk Res; 1992; 16(1):43-6. PubMed ID: 1732669
[TBL] [Abstract][Full Text] [Related]
11. Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study.
Nisse C; Lorthois C; Dorp V; Eloy E; Haguenoer JM; Fenaux P
Leukemia; 1995 Apr; 9(4):693-9. PubMed ID: 7723405
[TBL] [Abstract][Full Text] [Related]
12. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings.
Rigolin GM; Cuneo A; Roberti MG; Bardi A; Bigoni R; Piva N; Minotto C; Agostini P; De Angeli C; Del Senno L; Spanedda R; Castoldi G
Br J Haematol; 1998 Oct; 103(1):189-97. PubMed ID: 9792307
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemia and clonal chromosome aberrations in relation to past exposure to organic solvents.
Albin M; Björk J; Welinder H; Tinnerberg H; Mauritzson N; Johansson B; Billström R; Strömberg U; Mikoczy Z; Ahlgren T; Nilsson PG; Mitelman F; Hagmar L
Scand J Work Environ Health; 2000 Dec; 26(6):482-91. PubMed ID: 11201395
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Yarosh R; Roesler MA; Murray T; Cioc A; Hirsch B; Nguyen P; Warlick E; Poynter JN
Cancer Causes Control; 2021 Mar; 32(3):241-250. PubMed ID: 33392905
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification.
Mahmood R; Altaf C; Ahmed P; Khan SA; Malik HS
Turk J Haematol; 2018 May; 35(2):109-115. PubMed ID: 28588002
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of cytogenetic characteristics in patients with myelodysplastic syndrome].
Ma L; Zhong MH; Han CW; Wang JY; Cao YT; Ma YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1405-9. PubMed ID: 23257442
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population.
Lv L; Lin G; Gao X; Wu C; Dai J; Yang Y; Zou H; Sun H; Gu M; Chen X; Fu H; Bao L
Am J Hematol; 2011 Feb; 86(2):163-9. PubMed ID: 21264898
[TBL] [Abstract][Full Text] [Related]
18. Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease.
Goldberg H; Lusk E; Moore J; Nowell PC; Besa EC
Cancer Res; 1990 Nov; 50(21):6876-81. PubMed ID: 2208156
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features.
Wilson CS; Traweek ST; Slovak ML; Niland JC; Forman SJ; Brynes RK
Am J Clin Pathol; 1997 Oct; 108(4):369-77. PubMed ID: 9322588
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal abnormalities in primary myelodysplastic syndrome.
Rashid A; Khurshid M; Shaikh U; Adil S
J Coll Physicians Surg Pak; 2014 Sep; 24(9):632-5. PubMed ID: 25233965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
